Pierre Quartier

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

Helen J. Lachmann, Isabelle Koné‐Paut, Jasmin Kuemmerle‐Deschner et al. · New England Journal of Medicine · 2009 · 858 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Chronic Infantile Neurological Cutaneous and Articular Syndrome Is Caused by Mutations in CIAS1, a Gene Highly Expressed in Polymorphonuclear Cells and Chondrocytes

Jérôme Feldmann, Anne‐Marie Prieur, Pierre Quartier et al. · The American Journal of Human Genetics · 2002 · 741 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier et al. · New England Journal of Medicine · 2012 · 709 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Nicolino Ruperto, Daniel J. Lovell, Pierre Quartier et al. · The Lancet · 2008 · 554 citations

Medicine, Pediatrics, Pharmacotherapy +9

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Pierre Quartier, Florence Allantaz, Rolando Cimaz et al. · Annals of the Rheumatic Diseases · 2010 · 549 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +10